Galmed Pharmaceuticals Ltd.
EOCN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001595353
No open-market purchases or sales by Galmed Pharmaceuticals Ltd. insiders were filed in the last 90 days; 14 institutions reported holding it in 13F filings for Q2 2026, worth $85.9K in total; no superinvestor holds it.
13F holders, Q2 2021
Institutional positions in Galmed Pharmaceuticals Ltd. as of Jun 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 25
- −5 vs. Q1 2021
- Shares held
- 4.81M
- −849.2K (−15.0%) vs. Q1 2021
- Total value
- $14.6M
- −$4.79M (−24.7%) vs. Q1 2021
- New holders
- 3
- 3 more added
- Sold out
- 8
- 9 more reduced
Compare with Q1 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting EOCN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 14 | $85.9K |
| Q1 2026 | 16 | $71.2K |
| Q4 2025 | 17 | $166.4K |
| Q3 2025 | 14 | $102.0K |
| Q2 2025 | 15 | $140.2K |
| Q1 2025 | 13 | $80.4K |
| Q4 2024 | 12 | $142.8K |
| Q3 2024 | 10 | $38.3K |
| Q2 2024 | 13 | $112.9K |
| Q1 2024 | 13 | $57.6K |
| Q4 2023 | 14 | $248.8K |
| Q3 2023 | 17 | $428.2K |
| Q2 2023 | 12 | $419.1K |
| Q1 2023 | 21 | $878.3K |
| Q4 2022 | 22 | $1.21M |
| Q3 2022 | 25 | $803.6K |
| Q2 2022 | 22 | $1.70M |
| Q1 2022 | 23 | $4.47M |
| Q4 2021 | 24 | $7.05M |
| Q3 2021 | 26 | $11.8M |
| Q2 2021 | 25 | $14.6M |
| Q1 2021 | 30 | $19.4M |
Institutions, Q2 2021
Shares, value and share of portfolio for each institution holding Galmed Pharmaceuticals Ltd.; share changes are against Q1 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Bourgeon Capital Management LLC | 500 | $2.00K | 0.00% | 00.0% | Unchanged |
| McCarthy Asset Management, Inc. | 700 | $2.00K | 0.00% | 00.0% | Unchanged |
| Steward Partners Investment Advisory, LLC | 500 | $2.00K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 1,241 | $4.00K | 0.00% | −1,327−51.7% | Reduced |
| Federation des caisses Desjardins du Quebec | 2,500 | $7.60K | 0.00% | 00.0% | Unchanged |
| TSFG, LLC | 3,000 | $9.00K | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 6,330 | $19.0K | 0.00% | 00.0% | Unchanged |
| BlackRock Inc. | 9,116 | $28.0K | 0.00% | 00.0% | Unchanged |
| Susquehanna Fundamental Investments, LLC | 10,200 | $31.0K | 0.00% | −1,700−14.3% | Reduced |
| Brave Asset Management Inc | 11,470 | $35.0K | 0.01% | +11,470 | New |
| Simplex Trading, LLC | 12,068 | $36.0K | 0.00% | +12,068 | New |
| Two Sigma Advisers, LP | 15,200 | $46.0K | 0.00% | −2,300−13.1% | Reduced |
| Raymond James Financial Services Advisors, Inc. | 16,749 | $51.0K | 0.00% | −338−2.0% | Reduced |
| Jump Financial, LLC | 16,800 | $51.0K | 0.00% | +900+5.7% | Added |
| Geode Capital Management, LLC | 19,960 | $60.0K | 0.00% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 23,684 | $72.0K | 0.00% | +10,085+74.2% | Added |
| Squarepoint Ops LLC | 32,634 | $99.0K | 0.00% | −22,250−40.5% | Reduced |
| Rockefeller Capital Management L.P. | 35,419 | $107.0K | 0.00% | −1,030−2.8% | Reduced |
| Citadel Advisors LLC | 39,337 | $120.0K | 0.00% | +39,337 | New |
| Morgan Stanley | 184,200 | $560.0K | 0.00% | −1,352−0.7% | Reduced |
| P.A.W. Capital Corp | 200,000 | $608.0K | 0.52% | 00.0% | Unchanged |
| Raymond James & Associates | 207,865 | $632.0K | 0.00% | +58,894+39.5% | Added |
| Nantahala Capital Management, LLC | 944,631 | $2.87M | 0.16% | −268,909−22.2% | Reduced |
| Ibex Investors LLC | 1,220,794 | $3.71M | 2.25% | −304,206−19.9% | Reduced |
| BVF Inc | 1,799,694 | $5.47M | 0.21% | 00.0% | Unchanged |
| Baker Bros. Advisors LP | 0 | $0 | 0.00% | −184,927−100.0% | Sold out |
| California Public Employees Retirement System | 0 | $0 | 0.00% | −85,232−100.0% | Sold out |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −60,700−100.0% | Sold out |
| Goldman Sachs Group Inc | 0 | $0 | 0.00% | −26,419−100.0% | Sold out |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −16,700−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −3,418−100.0% | Sold out |
| Capital Analysts, LLC | 0 | $0 | 0.00% | −882−100.0% | Sold out |
| Reilly Financial Advisors, LLC | 0 | $0 | 0.00% | −250−100.0% | Sold out |